West Pharmaceutical Services, Inc.


SKU: WST Category:


West Pharmaceutical Services: Contract Manufacturing Expansion 


West Pharmaceutical Services, a globally recognized leader in innovative solutions for injectable drug administration, reported a strong start to the year 2024, despite several challenges in the market. The firm recorded a slight decrease in organic sales, operating profits and diluted EPS compared to Q1 2023 due to market dynamics, primarily inventory adjustments, and customer destocking, which is the reduction of excess inventory held by customers.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!